Aptose Biosciences Inc (APS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.381x

Based on the latest financial reports, Aptose Biosciences Inc (APS) has a cash flow conversion efficiency ratio of 0.381x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-7.41 Million ≈ $-5.36 Million USD) by net assets (CA$-19.45 Million ≈ $-14.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Aptose Biosciences Inc to measure how much of total assets are equity-financed.

Aptose Biosciences Inc - Cash Flow Conversion Efficiency Trend (1996–2024)

This chart illustrates how Aptose Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check APS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Aptose Biosciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aptose Biosciences Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PDZ Holdings Bhd KLSE:6254	0.138x
Pryme BV OL:PRYME	-1.603x
Aterian Inc NASDAQ:ATER	-0.069x
ABM International Limited NSE:ABMINTLLTD	0.002x
Clara Resources Australia Ltd AU:C7A	-0.096x
Provaris Energy Ltd AU:PV1	-2.619x
Mobile-health Network Solutions Class A Ordinary Shares NASDAQ:MNDR	-0.508x
Thai-German Products Public Company Limited BK:TGPRO	0.008x

Annual Cash Flow Conversion Efficiency for Aptose Biosciences Inc (1996–2024)

The table below shows the annual cash flow conversion efficiency of Aptose Biosciences Inc from 1996 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Aptose Biosciences Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-4.54 Million ≈ $-3.29 Million	CA$-35.98 Million ≈ $-26.03 Million	7.919x	-48.48%
2023-12-31	CA$-2.90 Million ≈ $-2.10 Million	CA$-44.59 Million ≈ $-32.26 Million	15.371x	+1894.75%
2022-12-31	CA$37.74 Million ≈ $27.30 Million	CA$-32.32 Million ≈ $-23.38 Million	-0.856x	-46.82%
2021-12-31	CA$74.24 Million ≈ $53.70 Million	CA$-43.30 Million ≈ $-31.33 Million	-0.583x	-104.68%
2020-12-31	CA$118.92 Million ≈ $86.02 Million	CA$-33.89 Million ≈ $-24.52 Million	-0.285x	-24.17%
2019-12-31	CA$93.93 Million ≈ $67.94 Million	CA$-21.56 Million ≈ $-15.59 Million	-0.230x	+86.07%
2018-12-31	CA$14.08 Million ≈ $10.19 Million	CA$-23.21 Million ≈ $-16.79 Million	-1.648x	-64.47%
2017-12-31	CA$10.20 Million ≈ $7.38 Million	CA$-10.22 Million ≈ $-7.40 Million	-1.002x	+39.69%
2016-12-31	CA$7.33 Million ≈ $5.30 Million	CA$-12.17 Million ≈ $-8.81 Million	-1.661x	-129.30%
2015-12-31	CA$13.65 Million ≈ $9.87 Million	CA$-9.89 Million ≈ $-7.15 Million	-0.725x	-84.19%
2014-12-31	CA$25.28 Million ≈ $18.28 Million	CA$-9.94 Million ≈ $-7.19 Million	-0.393x	-106.04%
2013-12-31	CA$-757.75K ≈ $-548.15K	CA$-4.94 Million ≈ $-3.57 Million	6.516x	+296.38%
2012-12-31	CA$-1.95 Million ≈ $-1.41 Million	CA$-3.21 Million ≈ $-2.32 Million	1.644x	+106.67%
2011-12-31	CA$244.66K ≈ $176.99K	CA$-6.03 Million ≈ $-4.36 Million	-24.661x	-459.21%
2010-12-31	CA$-513.68K ≈ $-371.59K	CA$-3.53 Million ≈ $-2.55 Million	6.865x	+694.85%
2009-12-31	CA$-7.66 Million ≈ $-5.54 Million	CA$-6.62 Million ≈ $-4.79 Million	0.864x	-67.36%
2008-12-31	CA$-3.87 Million ≈ $-2.80 Million	CA$-10.25 Million ≈ $-7.42 Million	2.646x	+131.98%
2007-12-31	CA$711.16K ≈ $514.45K	CA$-5.88 Million ≈ $-4.26 Million	-8.274x	-261.85%
2006-12-31	CA$-2.32 Million ≈ $-1.68 Million	CA$-11.87 Million ≈ $-8.58 Million	5.112x	+462.25%
2005-12-31	CA$10.57 Million ≈ $7.65 Million	CA$-14.92 Million ≈ $-10.79 Million	-1.411x	0.00%
2004-12-31	CA$10.57 Million ≈ $7.65 Million	CA$-14.92 Million ≈ $-10.79 Million	-1.411x	-43.83%
2003-12-31	CA$20.99 Million ≈ $15.19 Million	CA$-20.60 Million ≈ $-14.90 Million	-0.981x	-263.72%
2002-12-31	CA$28.89 Million ≈ $20.90 Million	CA$-7.79 Million ≈ $-5.64 Million	-0.270x	0.00%
2001-12-31	CA$28.89 Million ≈ $20.90 Million	CA$-7.79 Million ≈ $-5.64 Million	-0.270x	-56.21%
2000-12-31	CA$36.38 Million ≈ $26.32 Million	CA$-6.28 Million ≈ $-4.55 Million	-0.173x	-121.46%
1999-12-31	CA$45.89 Million ≈ $33.19 Million	CA$-3.58 Million ≈ $-2.59 Million	-0.078x	+95.88%
1998-12-31	CA$1.29 Million ≈ $932.14K	CA$-2.44 Million ≈ $-1.77 Million	-1.895x	-106.70%
1997-12-31	CA$3.30 Million ≈ $2.38 Million	CA$-3.02 Million ≈ $-2.19 Million	-0.917x	-141.90%
1996-12-31	CA$6.89 Million ≈ $4.99 Million	CA$-2.61 Million ≈ $-1.89 Million	-0.379x	--

About Aptose Biosciences Inc

TO:APS Canada Biotechnology

Market Cap

$4.43 Million

CA$6.13 Million CAD

Market Cap Rank

#28777 Global

#1296 in Canada

Share Price

CA$2.40

Change (1 day)

+0.00%

52-Week Range

CA$1.53 - CA$2.40

All Time High

CA$181.05